DOCSLIB.ORG

Targeted Disruption of PDE3B, but Not PDE3A, Protects Murine Heart From

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Targeted Disruption of PDE3B, but Not PDE3A, Protects Murine Heart From Targeted disruption of PDE3B, but not PDE3A, protects PNAS PLUS murine heart from ischemia/reperfusion injury Youn Wook Chunga,b,1,2, Claudia Lagranhac,1, Yong Chend, Junhui Sunc, Guang Tongc,e, Steven C. Hockmana, Faiyaz Ahmada, Shervin G. Esfahanif, Dahae H. Baef, Nazari Polidovitchg, Jian Wug, Dong Keun Rheea, Beom Seob Leeb,h, Marjan Gucekd, Mathew P. Danielsf, Christine A. Brantnerf, Peter H. Backxg,i, Elizabeth Murphyc, and Vincent C. Manganielloa,2 aCardiovascular and Pulmonary Branch, cSystems Biology Center, dProteomics Core Facility, and fElectron Microscopy Core Facility, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892; bYonsei Cardiovascular Research Institute, Yonsei University College of Medicine, Seoul 120-752, Korea; eDepartment of Cardiovascular Surgery, Guangzhou General Hospital of Guangzhou Military Command, Guangzhou, Guangdong 510010, China; gDepartments of Physiology and Medicine, University of Toronto, Toronto, ON M5S 3A8, Canada; hGraduate Program in Science for Aging, Yonsei University, Seoul 120-752, Korea; and iDivision of Cardiology, University Health Network, Toronto, ON M5S 3E2, Canada Edited by Joseph A. Beavo, University of Washington School of Medicine, Seattle, WA, and approved March 13, 2015 (received for review August 29, 2014) Although inhibition of cyclic nucleotide phosphodiesterase type 3 PDE3 inhibitors, e.g., milrinone, are thought to enhance (PDE3) has been reported to protect rodent heart against ischemia/ myocardial inotropic responses via cAMP/PKA regulation of + reperfusion (I/R) injury, neither the specific PDE3 isoform involved Ca2 cycling in the sarcoplasmic reticulum (SR) (1, 5). The nor the underlying mechanisms have been identified. Targeted PDE3 inhibitor cilostazol (6–9) and the PDE5 inhibitor sildenafil disruption of PDE3 subfamily B (PDE3B), but not of PDE3 sub- (10, 11) have been reported to protect hearts against ischemia/ family A (PDE3A), protected mouse heart from I/R injury in vivo reperfusion (I/R) injury in various species. Fukasawa et al. (8) and in vitro, with reduced infarct size and improved cardiac − − have suggested that cilostazol exerts its cardioprotective effect by function. The cardioprotective effect in PDE3B / heart was re- 2+ + activating mitochondrial Ca -activated K (mitoKCa) channels, versed by blocking cAMP-dependent PKA and by paxilline, an in- whose opening protects hearts against infarction (12). Further- hibitor of mitochondrial calcium-activated K channels, the opening more, studies have shown that the opening of mitoKCa channels of which is potentiated by cAMP/PKA signaling. Compared with WT is potentiated by cAMP-dependent PKA signaling (13), whereas mitochondria, PDE3B−/− mitochondria were enriched in antiapop- + PKC potentiates mitochondrial ATP-sensitive K (mitoKATP) totic Bcl-2, produced less reactive oxygen species, and more fre- channel activation (14). Kukreja and his associates have sug- quently contacted transverse tubules where PDE3B was localized − − gested that the cardioprotective effects of sildenafil are mediated with caveolin-3. Moreover, a PDE3B / mitochondrial fraction con- + by activation of both mitoK (10) and mitoK channels (11). taining connexin-43 and caveolin-3 was more resistant to Ca2 - ATP Ca Ischemic preconditioning (PreC), a process in which brief in- induced opening of the mitochondrial permeability transition pore. − − termittent episodes of ischemia and reperfusion protect the heart Proteomics analyses indicated that PDE3B / heart mitochondria from subsequent prolonged ischemic injury (15), initiates a number fractions were enriched in buoyant ischemia-induced caveolin-3– enriched fractions (ICEFs) containing cardioprotective proteins. Ac- of cardioprotective signaling pathways at the plasma membrane, which are transduced to mitochondria (16). According to the “sig- cumulation of proteins into ICEFs was PKA dependent and was ” achieved by ischemic preconditioning or treatment of WT heart nalosome hypothesis, cardioprotective [e.g., G protein-coupled with the PDE3 inhibitor cilostamide. Taken together, these find- ings indicate that PDE3B deletion confers cardioprotective effects Significance because of cAMP/PKA-induced preconditioning, which is associated with the accumulation of proteins with cardioprotective function in By catalyzing the destruction of cAMP and cGMP, cyclic nucleo- ICEFs. To our knowledge, our study is the first to define a role for tide phosphodiesterases (PDEs) regulate their intracellular con- PDE3B in cardioprotection against I/R injury and suggests PDE3B as a centrations and biological actions. Eleven distinct gene families target for cardiovascular therapies. (PDE1–PDE11) define the PDE superfamily. Most families contain several PDE genes. Two separate but related genes generate − − PDE3B / mice | protein kinase A | ischemia/reperfusion injury | PDE3 subfamilies PDE3A and PDE3B. Although inhibition of PDE3 signalosome | membrane repair protects rodent heart against ischemia/reperfusion (I/R) injury, the specific PDE3 isoform involved is undetermined. Using he two cyclic nucleotide phosphodiesterase type 3 (PDE3) PDE3A- and PDE3B-KO mice, we report that deletion of PDE3B, PHYSIOLOGY Tsubfamilies PDE3A and PDE3B are products of separate but but not PDE3A, protected mouse heart from I/R injury in vivo homologous genes. PDE3 isoforms hydrolyze both cAMP and cGMP and in vitro, via cAMP-induced preconditioning. To our knowl- edge, our study is the first to define a role for PDE3B in car- with high affinity (K <1 μM) in a mutually competitive manner and m dioprotection against I/R injury and suggests PDE3B as a target are important regulators of cyclic nucleotide signaling pathways for cardiovascular therapies. and responses in cardiomyocytes and vascular smooth muscle (1). PDE3A and PDE3B exhibit different patterns of expression. PDE3A Author contributions: Y.W.C., C.L., and V.C.M. designed research; Y.W.C., C.L., Y.C., J.S., G.T., is more abundant in platelets, airway and vascular smooth muscle, F.A., S.G.E., D.H.B., N.P., J.W., and B.S.L. performed research; S.C.H., D.K.R., M.G., and M.P.D. contributed new reagents/analytic tools; Y.W.C., Y.C., J.S., G.T., F.A., S.G.E., D.H.B., N.P., J.W., and cardiovascular tissues, whereas PDE3B is relatively more highly M.P.D., C.A.B., P.H.B., E.M., and V.C.M. analyzed data; and Y.W.C. and V.C.M. wrote expressed in tissues that are important in regulating energy metab- the paper. olism, including liver, pancreatic β cells, brown adipose tissue (BAT), The authors declare no conflict of interest. and white adipose tissue (WAT) (2). Little is known about their This article is a PNAS Direct Submission. 1 differential localization and functions when PDE3A and PDE3B are Y.W.C. and C.L. contributed equally to this work. 2To whom correspondence may be addressed. Email: [email protected] or manganiv@ presentinthesamecell.TogainfurtherinsightintospecificPDE3A nhlbi.nih.gov. and PDE3B functions in physiological contexts, we have generated This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. −/− −/− and studied PDE3A and PDE3B mice (3, 4). 1073/pnas.1416230112/-/DCSupplemental. www.pnas.org/cgi/doi/10.1073/pnas.1416230112 PNAS | Published online April 15, 2015 | E2253–E2262 Downloaded by guest on September 23, 2021 receptor (GPCR)-induced or ouabain-induced] signals are de- A SvJ129 WT PDE3B KO C57BL/6J WT PDE3A KO livered to mitochondria by specialized caveolae-derived vesicular structures, signalosomes, which contain a wide variety of receptors (e.g., GPCRs) and signaling molecules (e.g., Akt, Src, eNOS, and PKCe) that are assembled in lipid rafts and caveolae (17). In recent years, the role of lipid rafts and caveolae in cardiovascular signaling has attracted much attention (18), and adenylyl cyclases and PDEs have emerged as key players in shaping and organizing intracellular BC 80 *** 80 signaling microdomains (19-21). 70 70 Accumulating evidence implicates the mitochondrial perme- 60 60 ability transition (MPT) pore as a key effector of cardioprotection 50 50 against I/R injury, and reperfusion-induced elevation of reactive 40 40 30 30 oxygen species (ROS) can trigger the opening of the MPT pore, 20 20 resulting in ischemic injury, apoptosis, and cell death (16). A wide 10 Zone/ Ischemic Risk 10 range of cardioprotective signaling pathways converge on glycogen 0 Area Ventricular Total (%) 0 synthase kinase-3β (GSK-3β), and its inhibition directly and/or Zone(%) Infarct/Ischemic Risk indirectly regulates MPT pore-regulatory factors (e.g., cyclophilin DE7070 7070 D and voltage-dependent anion channels) and antiapoptotic Bcl-2 6060 † 6060 family members (22). Physical association between mitochondria 50 50 50 * 50 and the endoplasmic reticulum (ER) [via mitochondria-associated 4040 *‡ 4040 ER membranes (MAMs)] (23) or the SR (24) also may reduce 3030 *†‡ *†‡ 3030 2+ 2020 2020 reperfusion-induced mitochondrial Ca overload and consequent (%) size AAR Infarct size (%) 1010 1010 oxidative stress and thus block MPT pore opening (25). 00 00 In this study, we report that, 24 h after in vivo coronary artery Milrinone - + - + - + Milrinone - + - + - + ligation, I/R or, in a Langendorff cardiac I/R model system, infarct Saline+-+-+- Saline+-+-+- −/− −/− size is reduced in PDE3B heart, but not in PDE3A heart, WT 3A KO 3B KO WT 3A KO 3B KO compared with WT heart. This protective effect is most likely + −/− −/− caused by reduced production of ROS and reduced Ca2 -induced Fig. 1. PDE3B
Load more

Recommended publications
  • Pnas11138correction 14002..14003
    Corrections MEDICAL SCIENCES Correction for “Regulation of bone remodeling by vasopressin New, Alberta Zallone, and Mone Zaidi, which appeared in issue 46, explains the bone loss in hyponatremia,” by Roberto Tamma, November 12, 2013, of Proc Natl Acad Sci USA (110:18644–18649; Li Sun, Concetta Cuscito, Ping Lu, Michelangelo Corcelli, first published October 28, 2013; 10.1073/pnas.1318257110). Jianhua Li, Graziana Colaianni, Surinder S. Moonga, Adriana The authors note that Fig. 1 appeared incorrectly. The cor- Di Benedetto, Maria Grano, Silvia Colucci, Tony Yuen, Maria I. rected figure and its legend appear below. Fig. 1. Bone cells express Avprs. Immunofluorescence micrographs (A) and Western immunoblotting (B) show the expression of Avpr1α in osteoblasts and osteoclasts, and as a function of osteoblast (mineralization) and osteoclast (with Rankl) differentiation. The expression of Avp (ligand) and Avpr1α (receptor) in osteoblasts is regulated by 17β-estradiol, as determined by quantitative PCR (C) and Western immunoblotting (D). (Magnification: A,63×.) Because Avp is a small peptide, its precursor neurophysin II is measured. Statistics: Student t test, P values shown compared with 0 h. Stimulation of Erk phosphorylation − (p-Erk) as a function of total Erk (t-Erk) by Avp (10 8 M) in osteoclast precursors (preosteoclasts), osteoclasts (OC), and osteoblasts establishes functionality of − the Avpr1α in the presence or absence of the receptor inhibitor SR49059 (10 8 M) (E). Western immunoblotting showing the expression of Avpr2 in pre- −/− osteoclasts, OCs (F), and osteoblasts (G) isolated from Avpr1α mice, as well as in MC3T3.E1 osteoblast precursors (G). Functionality of Avpr2 was confirmed −/− by the demonstration that cells from Avpr1α mice remained responsive to AVP in reducing the expression of osteoblast differentiation genes, namely Runx2, Osx, Bsp, Atf4, Opn, and Osteocalcin (quantitative PCR, P values shown) (H).
    [Show full text]
  • Sat-196 How to Estimate Glomerular Filtration Rate
    ISN WCN 2019 ABSTRACTS 13 (28%) patients had CKD stage 3. 6/13 had low predicted risk of Nephrology, Melbourne, Australia, 8Austin Hospital, Nephrology, Heidel- berg, Australia, 9Monash Childrens Hospital, Nephrology, Australia, progression at 5 years of whom 4/6 progressed unexpectedly. 1/13 was 10 identified as having high risk at 5 years and that 1 patient progressed to Melbourne Genomics Health Alliance, Victorian Clinical Genetics Service, Melbourne, Australia, 11Australian Genomic Health Alliance, KidGen Renal CKD5D/T. Genetics Flagship, Australia, Australia, 12Royal Childrens Hospital, 6/18 CKD 3/4 patients with predicted low risk progressed to CKD5D/ Nephrology, Melbourne, Australia T unexpectedly. 1/6 had emergency abdominal surgery, 1/6 patient had Introduction: Genomic technologies enable the rapid and cost-effective unexplained rapid progression and 4/6 had acute upper gastro-intes- fi tinal haemorrhage causing terminal decline of kidney function. sequencing of DNA and have demonstrated a de nitive diagnosis in Conclusions: The number of patients analysed was small. The 8-vari- several patient groups. The clinical utility of whole exome sequencing able equation accurately predicted high risk of progression to CKD5D/T (WES) in a kidney disease cohort is not yet well established. We in 7/9 CKD3/4 patients. describe the patient characteristics and diagnostic yield of a cohort of Conversely, 6/18 patients with predicted low risk progressed to 200 patients with suspected genetic kidney disease referred for WES via CKD5D/T. Acute medical events including upper gastro-intestinal bleed a multidisciplinary renal genetics clinic. Methods: accounted for most instances of unexpected progression. 200 sequential patients were recruited into a prospective observational cohort study through five tertiary academic centres in Victoria, Australia.
    [Show full text]
  • Steroid-Dependent Regulation of the Oviduct: a Cross-Species Transcriptomal Analysis
    University of Kentucky UKnowledge Theses and Dissertations--Animal and Food Sciences Animal and Food Sciences 2015 Steroid-dependent regulation of the oviduct: A cross-species transcriptomal analysis Katheryn L. Cerny University of Kentucky, [email protected] Right click to open a feedback form in a new tab to let us know how this document benefits ou.y Recommended Citation Cerny, Katheryn L., "Steroid-dependent regulation of the oviduct: A cross-species transcriptomal analysis" (2015). Theses and Dissertations--Animal and Food Sciences. 49. https://uknowledge.uky.edu/animalsci_etds/49 This Doctoral Dissertation is brought to you for free and open access by the Animal and Food Sciences at UKnowledge. It has been accepted for inclusion in Theses and Dissertations--Animal and Food Sciences by an authorized administrator of UKnowledge. For more information, please contact [email protected]. STUDENT AGREEMENT: I represent that my thesis or dissertation and abstract are my original work. Proper attribution has been given to all outside sources. I understand that I am solely responsible for obtaining any needed copyright permissions. I have obtained needed written permission statement(s) from the owner(s) of each third-party copyrighted matter to be included in my work, allowing electronic distribution (if such use is not permitted by the fair use doctrine) which will be submitted to UKnowledge as Additional File. I hereby grant to The University of Kentucky and its agents the irrevocable, non-exclusive, and royalty-free license to archive and make accessible my work in whole or in part in all forms of media, now or hereafter known.
    [Show full text]
  • IL21R Expressing CD14+CD16+ Monocytes Expand in Multiple
    Plasma Cell Disorders SUPPLEMENTARY APPENDIX IL21R expressing CD14 +CD16 + monocytes expand in multiple myeloma patients leading to increased osteoclasts Marina Bolzoni, 1 Domenica Ronchetti, 2,3 Paola Storti, 1,4 Gaetano Donofrio, 5 Valentina Marchica, 1,4 Federica Costa, 1 Luca Agnelli, 2,3 Denise Toscani, 1 Rosanna Vescovini, 1 Katia Todoerti, 6 Sabrina Bonomini, 7 Gabriella Sammarelli, 1,7 Andrea Vecchi, 8 Daniela Guasco, 1 Fabrizio Accardi, 1,7 Benedetta Dalla Palma, 1,7 Barbara Gamberi, 9 Carlo Ferrari, 8 Antonino Neri, 2,3 Franco Aversa 1,4,7 and Nicola Giuliani 1,4,7 1Myeloma Unit, Dept. of Medicine and Surgery, University of Parma; 2Dept. of Oncology and Hemato-Oncology, University of Milan; 3Hematology Unit, “Fondazione IRCCS Ca’ Granda”, Ospedale Maggiore Policlinico, Milan; 4CoreLab, University Hospital of Parma; 5Dept. of Medical-Veterinary Science, University of Parma; 6Laboratory of Pre-clinical and Translational Research, IRCCS-CROB, Referral Cancer Center of Basilicata, Rionero in Vulture; 7Hematology and BMT Center, University Hospital of Parma; 8Infectious Disease Unit, University Hospital of Parma and 9“Dip. Oncologico e Tecnologie Avanzate”, IRCCS Arcispedale Santa Maria Nuova, Reggio Emilia, Italy ©2017 Ferrata Storti Foundation. This is an open-access paper. doi:10.3324/haematol. 2016.153841 Received: August 5, 2016. Accepted: December 23, 2016. Pre-published: January 5, 2017. Correspondence: [email protected] SUPPLEMENTAL METHODS Immunophenotype of BM CD14+ in patients with monoclonal gammopathies. Briefly, 100 μl of total BM aspirate was incubated in the dark with anti-human HLA-DR-PE (clone L243; BD), anti-human CD14-PerCP-Cy 5.5, anti-human CD16-PE-Cy7 (clone B73.1; BD) and anti-human CD45-APC-H 7 (clone 2D1; BD) for 20 min.
    [Show full text]
  • Annexin A2 Depletion Delays EGFR Endocytic Trafficking Via Cofilin
    Oncogene (2014) 33, 2610–2619 & 2014 Macmillan Publishers Limited All rights reserved 0950-9232/14 www.nature.com/onc ORIGINAL ARTICLE Annexin A2 depletion delays EGFR endocytic trafficking via cofilin activation and enhances EGFR signaling and metastasis formation M de Graauw1, L Cao2,5, L Winkel3,5, MHAM van Miltenburg4,SEleDe´ve´ dec1, M Klop1,KYan2, C Pont1, V-M Rogkoti1, A Tijsma1, A Chaudhuri1, R Lalai1, L Price1, F Verbeek2 and B van de Water1 Enhanced epidermal growth factor receptor (EGFR) activity has been strongly linked to breast cancer progression and mediators of EGFR endocytosis may well be involved. We developed a semi-automated high-content fluorescence microscopy-based EGFR endocytosis screen to identify proteins that mediate EGFR endocytosis in human HBL100 breast cancer cells. Knockdown of 172 individual endocytosis and actin-regulatory genes with small interfering RNAs led to the identification of 14 genes of which the contribution to EGFR endocytosis in breast cancer is until now poorly defined, including DNAJC6, GDI2, FGD6, HAX1, NECAP2 and AnxA2. We show that depletion of the actin and endocytosis regulatory protein annexin A2 (AnxA2) in a panel of four triple negative breast cancer (TNBC) cell lines affected EGFR endocytosis. Depletion of AnxA2 in the aggressive and highly metastatic MDA-MB-231 TNBC cell line resulted in the inhibition of EGFR transport beyond the early endosomes. This inhibition coincided with enhanced epidermal growth factor (EGF)-induced cell migration and downstream signaling via c-Jun N-terminal kinase (JNK) and Akt. Moreover, AnxA2 knockdown increased lung metastasis formation in mice. The effect of AnxA2 knockdown on EGFR endocytosis in MDA-MB-231 was related to dephosphorylation/activation of the actin-severing protein cofilin, as re-expression of an inactive S3E- cofilin mutant, but not an active S3A-cofilin mutant, re-established EGFR endocytosis to control levels.
    [Show full text]
  • Gene Alterations Identified by Expression Profiling in Tumor-Associated Endothelial Cells from Invasive Ovarian Carcinoma
    Research Article Gene Alterations Identified by Expression Profiling in Tumor-Associated Endothelial Cells from Invasive Ovarian Carcinoma Chunhua Lu,1 Tomas Bonome,3 Yang Li,1 Aparna A. Kamat,1 Liz Y. Han,1 Rosemarie Schmandt,1 Robert L. Coleman,1 David M. Gershenson,1 Robert B. Jaffe,4 MichaelJ. Birrer, 3 and AnilK. Sood 1,2 Departments of 1Gynecologic Oncology and 2Cancer Biology, University of Texas M. D. Anderson Cancer Center, Houston, Texas; 3Cell and Cancer Biology Branch, National Cancer Institute, Bethesda, Maryland; and 4Center for Reproductive Sciences, University of California, San Francisco, San Francisco, California Abstract the promise of such approaches. However, the full spectrum of Therapeutic strategies based on antiangiogenic approaches differences in the tumor vasculature compared with its normal are beginning to show great promise in clinical studies. counterpart is not known. Identification of additional targets on However, full realization of these approaches requires tumor endothelium may allow opportunities for developing new identification of key differences in gene expression between therapeutic approaches to inhibit angiogenesis in a tumor-specific endothelial cells from tumors versus their normal counter- manner. parts. Here, we examined gene expression differences in Higher levels of proangiogenic cytokines and angiogenesis are purified endothelial cells from 10invasive epithelial ovarian associated with an increased risk of metastasis and poor prognosis cancers and 5 normal ovaries using Affymetrix U133 Plus in ovarian cancer (5, 6). To date, a small number of breast, colon, 2.0microarrays. More than 400differentially expressed genes and brain cancers have been analyzed for gene expression changes were identified in tumor-associated endothelial cells.
    [Show full text]
  • 2812 Matrix Vesicles: Structure, Composition, Formation and Function in Ca
    [Frontiers in Bioscience 16, 2812-2902, June 1, 2011] Matrix vesicles: structure, composition, formation and function in calcification Roy E. Wuthier Department of Chemistry and Biochemistry, University of South Carolina, Columbia, SC 29208 TABLE OF CONTENTS 1. Abstract 2. Introduction 3. Morphology of matrix vesicles (MVs) 3.1. Conventional transmission electron microscopy 3.2. Cryofixation, freeze-substitution electron microscopy 3.3. Freeze-fracture studies 4. Isolation of MVs 4.1. Crude collagenase digestion methods 4.2. Non-collagenase dependent methods 4.3. Cell culture methods 4.4. Modified collagenase digestion methods 4.5. Other isolation methods 5. MV proteins 5.1. Early SDS-PAGE studies 5.2. Isolation and identification of major MV proteins 5.3. Sequential extraction, separation and characterization of major MV proteins 5.4. Proteomic characterization of MV proteins 6. MV-associated extracellular matrix proteins 6.1. Type VI collagen 6.2. Type X collagen 6.3. Proteoglycan link protein and aggrecan core protein 6.4. Fibrillin-1 and fibrillin-2 7. MV annexins – acidic phospholipid-dependent ca2+-binding proteins 7.1. Annexin A5 7.2. Annexin A6 7.3. Annexin A2 7.4. Annexin A1 7.5. Annexin A11 and Annexin A4 8. MV enzymes 8.1. Tissue-nonspecific alkaline phosphatase(TNAP) 8.1.1. Molecular structure 8.1.2. Amino acid sequence 8.1.3. 3-D structure 8.1.4. Disposition in the MV membrane 8.1.5. Catalytic properties 8.1.6. Collagen-binding properties 8.2. Nucleotide pyrophosphate phosphodiesterase (NPP1, PC1) 8.3. PHOSPHO-1 (Phosphoethanolamine/Phosphocholine phosphatase 8.4. Acid phosphatase 8.5.
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • Calcium Cycling Proteins and Heart Failure: Mechanisms and Therapeutics
    Calcium cycling proteins and heart failure: mechanisms and therapeutics Andrew R. Marks J Clin Invest. 2013;123(1):46-52. https://doi.org/10.1172/JCI62834. Review Series Ca2+-dependent signaling is highly regulated in cardiomyocytes and determines the force of cardiac muscle contraction. Ca2+ cycling refers to the release and reuptake of intracellular Ca2+ that drives muscle contraction and relaxation. In failing hearts, Ca2+ cycling is profoundly altered, resulting in impaired contractility and fatal cardiac arrhythmias. The key defects in Ca2+ cycling occur at the level of the sarcoplasmic reticulum (SR), a Ca2+ storage organelle in muscle. Defects in the regulation of Ca2+ cycling proteins including the ryanodine receptor 2, cardiac (RyR2)/Ca2+ release channel macromolecular complexes and the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase 2a (SERCA2a)/phospholamban complex contribute to heart failure. RyR2s are oxidized, nitrosylated, and PKA hyperphosphorylated, resulting in “leaky” channels in failing hearts. These leaky RyR2s contribute to depletion of Ca2+ from the SR, and the leaking Ca2+ depolarizes cardiomyocytes and triggers fatal arrhythmias. SERCA2a is downregulated and phospholamban is hypophosphorylated in failing hearts, resulting in impaired SR Ca2+ reuptake that conspires with leaky RyR2 to deplete SR Ca2+. Two new therapeutic strategies for heart failure (HF) are now being tested in clinical trials: (a) fixing the leak in RyR2 channels with a novel class of Ca2+-release channel stabilizers called Rycals and (b) increasing expression of SERCA2a to improve SR Ca2+ reuptake with viral-mediated gene therapy. There are many potential opportunities for additional mechanism-based therapeutics involving the machinery […] Find the latest version: https://jci.me/62834/pdf Review series Calcium cycling proteins and heart failure: mechanisms and therapeutics Andrew R.
    [Show full text]
  • Phospholipid Flipping Facilitates Annexin Translocation Across Membranes
    bioRxiv preprint doi: https://doi.org/10.1101/241976; this version posted January 2, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 Phospholipid flipping facilitates annexin translocation across membranes Sarah E Stewart1*, Avraham Ashkenazi2*, Athena Williamson1, David C Rubinsztein2,3† and Kevin Moreau1† 1University of Cambridge, Metabolic Research Laboratories, Wellcome Trust-Medical Research Council Institute of Metabolic Science, Cambridge, CB2 0QQ, U.K 2University of Cambridge, Department of Medical Genetics, Cambridge Institute for Medical Research, Wellcome/MRC Building, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0XY, UK 3UK Dementia Research Institute, Cambridge Biomedical Campus, Cambridge Biomedical Campus, Hills Road, Cambridge, UK. *Co-first authors † Co-senior authors For correspondence: KM: [email protected], DCR: [email protected] Abstract Annexins are phospholipid binding proteins that somehow translocate from the inner leaflet of the plasma membrane to the outer leaflet 1-4. For example, Annexin A2 is known to localise to the outer leaflet of the plasma membrane (cell surface) where it is involved in plasminogen activation leading to fibrinolysis and cell migration, among other functions 1,5-9. Despite having well described extracellular functions, the mechanism of annexin transport from the cytoplasmic inner leaflet to the extracellular outer leaflet of the plasma membrane remains unclear. As annexin A2 and A5 bind to negatively charged lipid head groups of the inner and outer leaflets of the plasma membrane in a calcium-dependent manner 4,10, we hypothesised that lipid remodelling may be involved in their translocation to the cell surface.
    [Show full text]
  • Proteomic Analysis of Exosome-Like Vesicles Derived from Breast Cancer Cells
    ANTICANCER RESEARCH 32: 847-860 (2012) Proteomic Analysis of Exosome-like Vesicles Derived from Breast Cancer Cells GEMMA PALAZZOLO1, NADIA NINFA ALBANESE2,3, GIANLUCA DI CARA3, DANIEL GYGAX4, MARIA LETIZIA VITTORELLI3 and IDA PUCCI-MINAFRA3 1Institute for Biomedical Engineering, Laboratory of Biosensors and Bioelectronics, ETH Zurich, Switzerland; 2Department of Physics, University of Palermo, Palermo, Italy; 3Centro di Oncobiologia Sperimentale (C.OB.S.), Oncology Department La Maddalena, Palermo, Italy; 4Institute of Chemistry and Bioanalytics, University of Applied Sciences Northwestern Switzerland FHNW, Muttenz, Switzerland Abstract. Background/Aim: The phenomenon of membrane that vesicle production allows neoplastic cells to exert different vesicle-release by neoplastic cells is a growing field of interest effects, according to the possible acceptor targets. For instance, in cancer research, due to their potential role in carrying a vesicles could potentiate the malignant properties of adjacent large array of tumor antigens when secreted into the neoplastic cells or activate non-tumoral cells. Moreover, vesicles extracellular medium. In particular, experimental evidence show could convey signals to immune cells and surrounding stroma that at least some of the tumor markers detected in the blood cells. The present study may significantly contribute to the circulation of mammary carcinoma patients are carried by knowledge of the vesiculation phenomenon, which is a critical membrane-bound vesicles. Thus, biomarker research in breast device for trans cellular communication in cancer. cancer can gain great benefits from vesicle characterization. Materials and Methods: Conditioned medium was collected The phenomenon of membrane release in the extracellular from serum starved MDA-MB-231 sub-confluent cell cultures medium has long been known and was firstly described by and exosome-like vesicles (ELVs) were isolated by Paul H.
    [Show full text]
  • Calmodulin Dependent Wound Repair in Dictyostelium Cell Membrane
    cells Article Ca2+–Calmodulin Dependent Wound Repair in Dictyostelium Cell Membrane Md. Shahabe Uddin Talukder 1,2, Mst. Shaela Pervin 1,3, Md. Istiaq Obaidi Tanvir 1, Koushiro Fujimoto 1, Masahito Tanaka 1, Go Itoh 4 and Shigehiko Yumura 1,* 1 Graduate School of Sciences and Technology for Innovation, Yamaguchi University, Yamaguchi 753-8511, Japan; [email protected] (M.S.U.T.); [email protected] (M.S.P.); [email protected] (M.I.O.T.); [email protected] (K.F.); [email protected] (M.T.) 2 Institute of Food and Radiation Biology, AERE, Bangladesh Atomic Energy Commission, Savar, Dhaka 3787, Bangladesh 3 Rajshahi Diabetic Association General Hospital, Luxmipur, Jhautala, Rajshahi 6000, Bangladesh 4 Department of Molecular Medicine and Biochemistry, Akita University Graduate School of Medicine, Akita 010-8543, Japan; [email protected] * Correspondence: [email protected]; Tel./Fax: +81-83-933-5717 Received: 2 April 2020; Accepted: 21 April 2020; Published: 23 April 2020 Abstract: Wound repair of cell membrane is a vital physiological phenomenon. We examined wound repair in Dictyostelium cells by using a laserporation, which we recently invented. We examined the influx of fluorescent dyes from the external medium and monitored the cytosolic Ca2+ after wounding. The influx of Ca2+ through the wound pore was essential for wound repair. Annexin and ESCRT components accumulated at the wound site upon wounding as previously described in animal cells, but these were not essential for wound repair in Dictyostelium cells. We discovered that calmodulin accumulated at the wound site upon wounding, which was essential for wound repair.
    [Show full text]